1. Home
  2. PLBC vs ITOS Comparison

PLBC vs ITOS Comparison

Compare PLBC & ITOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLBC
  • ITOS
  • Stock Information
  • Founded
  • PLBC 1980
  • ITOS 2011
  • Country
  • PLBC United States
  • ITOS United States
  • Employees
  • PLBC N/A
  • ITOS N/A
  • Industry
  • PLBC Finance Companies
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PLBC Finance
  • ITOS Health Care
  • Exchange
  • PLBC Nasdaq
  • ITOS Nasdaq
  • Market Cap
  • PLBC 236.7M
  • ITOS 270.7M
  • IPO Year
  • PLBC 2005
  • ITOS 2020
  • Fundamental
  • Price
  • PLBC $41.97
  • ITOS $9.99
  • Analyst Decision
  • PLBC Buy
  • ITOS Hold
  • Analyst Count
  • PLBC 3
  • ITOS 6
  • Target Price
  • PLBC $57.67
  • ITOS $10.60
  • AVG Volume (30 Days)
  • PLBC 8.8K
  • ITOS 1.8M
  • Earning Date
  • PLBC 07-16-2025
  • ITOS 08-07-2025
  • Dividend Yield
  • PLBC 2.86%
  • ITOS N/A
  • EPS Growth
  • PLBC 3.33
  • ITOS N/A
  • EPS
  • PLBC 4.95
  • ITOS N/A
  • Revenue
  • PLBC $84,001,000.00
  • ITOS $35,000,000.00
  • Revenue This Year
  • PLBC $19.95
  • ITOS N/A
  • Revenue Next Year
  • PLBC $22.19
  • ITOS N/A
  • P/E Ratio
  • PLBC $8.48
  • ITOS N/A
  • Revenue Growth
  • PLBC 9.14
  • ITOS 177.89
  • 52 Week Low
  • PLBC $32.50
  • ITOS $4.80
  • 52 Week High
  • PLBC $51.33
  • ITOS $18.13
  • Technical
  • Relative Strength Index (RSI)
  • PLBC 43.40
  • ITOS 65.96
  • Support Level
  • PLBC $41.50
  • ITOS $9.93
  • Resistance Level
  • PLBC $43.19
  • ITOS $10.21
  • Average True Range (ATR)
  • PLBC 1.05
  • ITOS 0.18
  • MACD
  • PLBC -0.14
  • ITOS -0.11
  • Stochastic Oscillator
  • PLBC 19.94
  • ITOS 18.07

About PLBC Plumas Bancorp

Plumas Bancorp provides various banking products and services in Northeastern California and Northwestern Nevada. It provides various deposit products such as checking, interest-bearing checking, business sweep, public funds sweep, savings, time deposit, and retirement accounts. The bank's loan portfolio consists of commercial real estate loans; commercial and industrial loans; consumer loans; agricultural loans; residential real estate loans, and construction and land development loans. The bank generates revenue from loans and investment securities in its portfolio and, to a lesser extent, service fees.

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

Share on Social Networks: